# Crossover Bioequivalence Study of Tinidazole 500 mg Tablets Under Fed Conditions

> **NCT01591889** · PHASE1 · COMPLETED · sponsor: **Roxane Laboratories** · enrollment: 28 (actual)

## Conditions studied

- Trichomoniasis

## Interventions

- **DRUG:** Tinidazole
- **DRUG:** Tinidazole

## Key facts

- **NCT ID:** NCT01591889
- **Lead sponsor:** Roxane Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2018-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01591889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01591889, "Crossover Bioequivalence Study of Tinidazole 500 mg Tablets Under Fed Conditions". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01591889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*